...
search icon
inzy-img

Inozyme Pharma Inc, Common Stock

INZY

NSQ

$1.45

-$0.05

(-3.33%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$93.47M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
402.54K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.54
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.24 L
$7.79 H
$1.45

About Inozyme Pharma Inc, Common Stock

Inozyme Pharma, Inc., a clinical-stage rare disease biopharmaceutical company, focuses on developing novel therapeutics for the treatment of vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant, genetically engineered, and fusion protein for the treatment of ENPP1 and ABCC6 deficiencies, as well as patients with end-stage kidney disease receiving hemodialysis. It has a license agreement with Yale University for specified therapeutic and prophylactic products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameINZYSectorS&P500
1-Week Return0.69%-0.3%0.78%
1-Month Return-48.58%4.81%2.99%
3-Month Return-64.63%-1.8%1.84%
6-Month Return-66.36%0.29%17%
1-Year Return-72.85%1.43%21.81%
3-Year Return-78.83%10.87%35.62%
5-Year Return-91.73%42.11%82.63%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue83.00K217.00K1.05M1.18M1.29M[{"date":"2019-12-31","value":6.41,"profit":true},{"date":"2020-12-31","value":16.77,"profit":true},{"date":"2021-12-31","value":81.3,"profit":true},{"date":"2022-12-31","value":90.96,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit(83.00K)(217.00K)(1.05M)(1.18M)(1.29M)[{"date":"2019-12-31","value":-8300000,"profit":false},{"date":"2020-12-31","value":-21700000,"profit":false},{"date":"2021-12-31","value":-105200000,"profit":false},{"date":"2022-12-31","value":-117700000,"profit":false},{"date":"2023-12-31","value":-129400000,"profit":false}]
Gross Margin(Infinity%)(Infinity%)(Infinity%)(Infinity%)(Infinity%)[{"date":"2019-12-31","value":null,"profit":false},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]
Operating Expenses20.81M57.04M56.65M68.67M75.64M[{"date":"2019-12-31","value":27.5,"profit":true},{"date":"2020-12-31","value":75.41,"profit":true},{"date":"2021-12-31","value":74.88,"profit":true},{"date":"2022-12-31","value":90.79,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(20.81M)(57.04M)(56.65M)(68.67M)(75.64M)[{"date":"2019-12-31","value":-2080600000,"profit":false},{"date":"2020-12-31","value":-5704100000,"profit":false},{"date":"2021-12-31","value":-5664600000,"profit":false},{"date":"2022-12-31","value":-6867500000,"profit":false},{"date":"2023-12-31","value":-7564500000,"profit":false}]
Total Non-Operating Income/Expense2.19M987.00K233.00K3.55M8.54M[{"date":"2019-12-31","value":25.61,"profit":true},{"date":"2020-12-31","value":11.55,"profit":true},{"date":"2021-12-31","value":2.73,"profit":true},{"date":"2022-12-31","value":41.51,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(19.72M)(56.42M)(56.62M)(67.06M)(71.17M)[{"date":"2019-12-31","value":-1972400000,"profit":false},{"date":"2020-12-31","value":-5642400000,"profit":false},{"date":"2021-12-31","value":-5662400000,"profit":false},{"date":"2022-12-31","value":-6706100000,"profit":false},{"date":"2023-12-31","value":-7116900000,"profit":false}]
Income Taxes(1.11M)(587.00K)(211.00K)(1.61M)-[{"date":"2019-12-31","value":-110600000,"profit":false},{"date":"2020-12-31","value":-58700000,"profit":false},{"date":"2021-12-31","value":-21100000,"profit":false},{"date":"2022-12-31","value":-161400000,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes(18.62M)(55.84M)(56.41M)(65.45M)-[{"date":"2019-12-31","value":-1861800000,"profit":false},{"date":"2020-12-31","value":-5583700000,"profit":false},{"date":"2021-12-31","value":-5641300000,"profit":false},{"date":"2022-12-31","value":-6544700000,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income From Continuous Operations(19.72M)(56.42M)(56.62M)(67.26M)(68.17M)[{"date":"2019-12-31","value":-1972400000,"profit":false},{"date":"2020-12-31","value":-5642400000,"profit":false},{"date":"2021-12-31","value":-5662400000,"profit":false},{"date":"2022-12-31","value":-6725900000,"profit":false},{"date":"2023-12-31","value":-6816900000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(18.62M)(55.84M)(56.41M)(65.45M)(71.17M)[{"date":"2019-12-31","value":-1861800000,"profit":false},{"date":"2020-12-31","value":-5583700000,"profit":false},{"date":"2021-12-31","value":-5641300000,"profit":false},{"date":"2022-12-31","value":-6544700000,"profit":false},{"date":"2023-12-31","value":-7116900000,"profit":false}]
EPS (Diluted)-(10.99)(2.39)(1.89)(1.37)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-1099,"profit":false},{"date":"2021-12-31","value":-239,"profit":false},{"date":"2022-12-31","value":-189,"profit":false},{"date":"2023-12-31","value":-137,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

INZY
Cash Ratio 7.17
Current Ratio 7.68

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

INZY
ROA (LTM) -35.69%
ROE (LTM) -79.42%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

INZY
Debt Ratio Lower is generally better. Negative is bad. 0.42
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.58

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

INZY
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 1.16
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Inozyme Pharma Inc share price today?

Inozyme Pharma Inc (INZY) share price today is $1.45

Can Indians buy Inozyme Pharma Inc shares?

Yes, Indians can buy shares of Inozyme Pharma Inc (INZY) on Vested. To buy Inozyme Pharma Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in INZY stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Inozyme Pharma Inc be purchased?

Yes, you can purchase fractional shares of Inozyme Pharma Inc (INZY) via the Vested app. You can start investing in Inozyme Pharma Inc (INZY) with a minimum investment of $1.

How to invest in Inozyme Pharma Inc shares from India?

You can invest in shares of Inozyme Pharma Inc (INZY) via Vested in three simple steps:

  • Click on Sign Up or Invest in INZY stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Inozyme Pharma Inc shares
What is Inozyme Pharma Inc 52-week high and low stock price?

The 52-week high price of Inozyme Pharma Inc (INZY) is $7.79. The 52-week low price of Inozyme Pharma Inc (INZY) is $1.24.

What is Inozyme Pharma Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Inozyme Pharma Inc (INZY) is 1.16

What is the Market Cap of Inozyme Pharma Inc?

The market capitalization of Inozyme Pharma Inc (INZY) is $93.47M

What is Inozyme Pharma Inc’s stock symbol?

The stock symbol (or ticker) of Inozyme Pharma Inc is INZY

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top